KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Operating Margin: 2017-2025

Historic Operating Margin for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Sep 2025 value amounting to 8.97%.

  • Amneal Pharmaceuticals' Operating Margin fell 368.00% to 8.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 12.19%, marking a year-over-year increase of 519.00%. This contributed to the annual value of 8.92% for FY2024, which is 39.00% up from last year.
  • According to the latest figures from Q3 2025, Amneal Pharmaceuticals' Operating Margin is 8.97%, which was down 41.67% from 15.37% recorded in Q2 2025.
  • Amneal Pharmaceuticals' Operating Margin's 5-year high stood at 15.37% during Q2 2025, with a 5-year trough of -35.51% in Q2 2022.
  • Over the past 3 years, Amneal Pharmaceuticals' median Operating Margin value was 12.20% (recorded in 2023), while the average stood at 9.80%.
  • Its Operating Margin has fluctuated over the past 5 years, first crashed by 4,805bps in 2022, then surged by 4,888bps in 2023.
  • Amneal Pharmaceuticals' Operating Margin (Quarterly) stood at 2.08% in 2021, then soared by 383bps to 5.91% in 2022, then slumped by 361bps to 2.30% in 2023, then spiked by 807bps to 10.38% in 2024, then plummeted by 368bps to 8.97% in 2025.
  • Its last three reported values are 8.97% in Q3 2025, 15.37% for Q2 2025, and 14.43% during Q1 2025.